LAUREN SURROCK: Open Payments
NPI 1033493309 · FRANKENMUTH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,434 in 62 payments from 20 companies in 2025. Trend: 2023 $482 · 2024 $1,672 · 2025 $1,434
Food & beverage: $1,285Education: $149
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $324 |
| Astellas Pharma US Inc | 4 | $191 |
| MERZ NORTH AMERICA, INC. | 1 | $178 |
| AstraZeneca Pharmaceuticals LP | 8 | $174 |
| PFIZER INC. | 6 | $109 |
| Novo Nordisk Inc | 4 | $74 |
| Lundbeck LLC | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Abbott Laboratories | 2 | $41 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
Products named: QULIPTA, AIRSUPRA, REXULTI, UBRELVY, NURTEC ODT, PREVNAR 20, Kerendia, Veozah.
Industry payments across MI — which companies pay providers there.
